Pfizer CEO warns German investment at risk over drug pricing policies
www.reuters.com/world/pfizer...
Pfizer is reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said in a letter to Chancellor Friedrich Merz, the latest drugmaker to react to government policy propos...
